Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHS SY ICB -Community Pharmacy COVID-19 Triage, Assessment & Prescribing Service

NHS South Yorkshire Integrated Care Board · award, contract

Tender information last checkedLast checked 2 Oct 2026, 18:21.

Opportunity overview

Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Contract value
£40k
Awarded
Not supplied
Contract signed
20 Apr 2026
Award ID
036719-2026-1
Status
active
Identifier
00496833
Location
Sheffield, UKE32, S3 8HT, United Kingdom

Classification

  • CPV85149000 — Pharmacy services

Lots

  • Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.<br/><br/>This notice is an intention to award a contract under the most suitable provider process.<br/><br/>The approximate lifetime value of the service is £40,000.<br/><br/>This is a new service.<br/><br/>The service will run from 01/06/2026 to 31/05/2028Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-066c8c
Status
complete
Main Procurement Category
services
Procurement Method
limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2024 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 5th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>The decision maker was: SY Integrated Pharmacy and Medicines Optimisation Programme Manager<br/><br/>No conflicts of interest were identified.<br/><br/>A F01 PIN notice (2026/S 000-024193) was published on 17th March 2026 asking potential providers for the service to responde to 6 questions, relating to providing the service. This was treated as a market engagement exercise to identify any providers that SY ICB were not aware of.<br/><br/>The 6 questions were:<br/><br/>1. Mobilisation - Key Criteria 4 - improving access, reducing health inequalities and facilitating choice.<br/>2. Service Delivery - Key Criteria 3 - integration, collaboration and service sustainability<br/>3. Organisational Details - Key Criteria 1 – Quality & Innovation<br/>4. Business Continuity - Key criteria 4 - improving access, reducing health inequalities and facilitating choice<br/>5. Value - Key Criteria 2. Value<br/>6. Social Value - Key Criteria 5 Social Value<br/><br/>All submissions were evaluated and moderated to provide a score for each provider's submission and the submission with the highest moderated score has been appointed as the preferred supplier. It is the intention to award the contract to this preferred supplier.

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
85149000
Description
Pharmacy services

Procedure reasons

Entry 1
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Id
D_OUTSIDE_SCOPE
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Description
Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.<br/><br/>This notice is an intention to award a contract under the most suitable provider process.<br/><br/>The approximate lifetime value of the service is £40,000.<br/><br/>This is a new service.<br/><br/>The service will run from 01/06/2026 to 31/05/2028
Has Options
No
Status
cancelled

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key criteria
Type
quality
Description
100
Criterion 2
Name
Cost
Type
cost
Description
0

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKE3

Delivery Location

Description
South Yorkshire

Buyer, suppliers and contacts

Organisation 1
Name
NHS South Yorkshire Integrated Care Board
Id
GB-FTS-113634

Identifier

Legal Name
NHS South Yorkshire Integrated Care Board

Address

Street Address
197 Eyre Street
Locality
Sheffield
Region
UKE32
Postal Code
S1 3FG
Country Name
United Kingdom

Contact

Name
Neill Scott

Roles

buyer

Details

Classifications

Entry 1
Scheme
TED_CA_TYPE
Id
BODY_PUBLIC
Description
Body governed by public law
Entry 2
Scheme
COFOG
Id
07
Description
Health
Organisation 2
Name
Associated Chemists (Wicker) Ltd
Id
GB-FTS-180560

Identifier

Legal Name
Associated Chemists (Wicker) Ltd
Id
00496833

Address

Street Address
61-65 Wicker Sheffield
Locality
Sheffield
Region
UKE32
Postal Code
S3 8HT
Country Name
United Kingdom

Contact

Telephone
+44 1142727676

Roles

supplier

Details

Scale
sme
Organisation 3
Name
Independent Choice and Procurement Panel.
Id
GB-FTS-108768

Identifier

Legal Name
Independent Choice and Procurement Panel.

Address

Street Address
Wellington House
Locality
London
Postal Code
SE1 8UG
Country Name
United Kingdom

Roles

reviewBody

Details

Award information

Award 1
Id
036719-2026-1
Status
active

Related lots

1

Suppliers

Supplier 1
Id
GB-FTS-180560
Name
Associated Chemists (Wicker) Ltd

Contracts and changes

Entry 1
Id
036719-2026-1
Award ID
036719-2026-1
Status
active
Date Signed
21 Apr 2026, 00:00

Value

Amount
40,000
Currency
GBP

Recorded locations

  • Buyer location · Sheffield · UKE32 · S1 3FG · United Kingdom
  • Delivery location · UKE3

Notice and amendment history

2 published notice versions reviewed by ProcuraAxis.

2 VERSIONS
  1. 024193-2026planning ·
  2. 036719-2026award, contract ·